Kidney | Non Therapeutic | Supportive Care

Kidney Disease in Patients Receiving Immune Checkpoint Inhibitor Therapy

Volunteers
Health Professionals

What is the purpose of this trial?

The overall goal of this project is to provide clinicians with non-invasive acute kidney injury (AKI) biomarkers in patients who develop kidney injury while on Immune Checkpoint Inhibitor therapy and to understand the impact of early acute kidney injury (AKI)/acute interstitial nephritis (AIN) and other predictors on long-term chronic kidney disease risk in cancer survivors.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Melissa Shaw

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Dennis G Moledina, MD, PhD, FASN
Associate Professor of Medicine (Nephrology); Director, Kidney BioBank, Internal Medicine

Sub-Investigators

Last Updated
08/15/2024
Study HIC
#2000033212